Welcome to the e-CCO Library!

P343: Maintenance of deep remission in Crohn’s disease after switching from anti–TNF to ustekinumab.
Year: 2021
Source: ECCO'21 Virtual
Authors: Mantzaris, G.(1);Vraka, M.(1);Beka, H.(1);Georgiadi, T.(1);Albani, F.(1);Veretanos, C.(1);Mountaki, K.(1);Trikola, A.(1);Archavlis, E.(1);Christidou, A.(1);Manolakis, A.(1);Viazis, N.(1);Karampekos, G.(1);Philippidis, G.(1);Hatzievangelinou, C.(1);Tsatsa, A.(1);Georgiadou, A.(1);Panagopoulou, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P343: The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease and the relationship with biochemical markers of disease activity
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Diederen1, D. Hoekman*1, T. Hummel2, T. de Meij3, B. Koot1, M. Tabbers1, A. Vlieger4, A. Kindermann1, M. Benninga1

Created: Friday, 22 February 2019, 9:49 AM
P344 Effectiveness of ustekinumab in refractory Crohn’s disease: A real-life experience in a tertiary referral centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Truyens1,2,3, J. Geldof1, G. Dewitte1, E. Glorieus1, P. Hindryckx1,3, T. Lobaton Ortega1,3

Created: Thursday, 30 January 2020, 10:12 AM
P344: Diverting ileostomy in Inflammatory Bowel Disease's surgery: the real clinical cost analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ascari, F.(1)*;Barugola, G.(2);Ruffo, G.(2);
Created: Friday, 14 July 2023, 11:05 AM
P344: Effectiveness and safety of switching patients with inflammatory bowel disease from originator infliximab to CT-P13: systematic review and meta-analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: Hanzel, J.(1,2);Strik, A.(2);Gecse, K.(2);D'Haens, G.(2);Dreesen, E.(3,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P344: Epidemiology of clostridium difficile infections in IBD over two decades
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Moens1,2*, B. Verstockt1,2, K. Machiels2, P. Bossuyt3, A. Verdonck4, K. Lagrou4, S. Vermeire1,2, M. Ferrante1,2

Created: Thursday, 21 February 2019, 9:14 AM
P344: Non-adherence to medical therapy is associated with hospitalisations and the development of active disease in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Severs*1, H. H. Fidder1, M.-J. Mangen2, M. E. van der Valk1, M. van der Have1, A. A. van Bodegraven3, 4, C. H. M. Clemens5, G. Dijkstra6, J. M. Jansen7, D. J. de Jong8, N. Mahmmod9, P. C. van de Meeberg10, A. E. van der Meulen- de Jong11, M. Pierik12, C. Y. Ponsioen13, M. J. L. Romberg- Camps3, P. D. Siersema1, J. R. Vermeijden14, J. van der Woude15, P. N. Zuithoff16, B. Oldenburg1

Created: Friday, 22 February 2019, 9:49 AM
P344: Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Ungaro*1, M. Fenster1, C. Dimopoulos1, A. Patel2, P. Deepak3, G. Syal4, A. Yarur5, R. Hirten1, G. Christophi3, A. Khatiwada3, B. Lin5, J-F. Colombel1, C. Ha4, R. Weisshof6, P. Beniwal-Patel5, B. Cohen1, J. Pekow6

Created: Friday, 22 February 2019, 9:41 AM
P344: Vitamin D-Induced alterations in Cytokine levels lower the risk of clinical relapse in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gubatan J.M., Mitsuhashi S., Longhi M.S., Zenlea T., Rosenberg L., Robson S., Moss A.

Created: Wednesday, 20 February 2019, 10:36 AM
P344: What our patients are looking for - the common fields of interest in IBD patients: A Google Trends Analysis
Year: 2022
Source: ECCO'22
Authors: Zarchi, R.(1);Elgressy, A.(2);Ben-Horin, S.(2);Kopylov, U.(2);
Created: Friday, 11 February 2022, 3:52 PM
P345 Lack of anti-TNF drugs levels in fistula tissue: A reason for non-response in Crohn’s perianal fistula?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Adegbola1, M. Sarafian2, K. Sahnan1, A. Pechlivanis2, R. Phillips1, C. Knowles3, J. Haddow4, J. Warusavitarne1, O. Faiz1, P. Tozer1, E. Holmes2, A. Hart1

Created: Thursday, 30 January 2020, 10:12 AM
P345: Capsule endoscopy in the diagnostic process of suspected Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hennlich, B.(1)*;Madl, C.(2);Pachofszky, T.(2);
Created: Friday, 14 July 2023, 11:05 AM
P345: Food-related quality of life in adults with Inflammatory Bowel Disease is influenced by restrictive eating behaviour, disease activity and surgery: a prospective multi-centre study
Year: 2021
Source: ECCO'21 Virtual
Authors: Day, A.(1,2);Yao, C.K.(3);Costello, S.(2,4);Andrews, J.(2,5);Bryant, R.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P345: Impact of aphthous colitis at diagnosis on Crohn’s disease outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Delattre1*, I. Nion-Larmurier1, A. Bourrier1, C. Landman1, G. Le Gall2, J. Kirchgesner1, H. Sokol1, L. Beaugerie1, J. Cosnes1, P. Seksik1

Created: Thursday, 21 February 2019, 9:14 AM
P345: Inconsistency between electronic data of patient's adherence and self reported adherence score
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Broide E.*1,2, Ein Dor A.1,3, Ruhimovich N.4, Shitrit A.B.5, Benjaminov F.2, Matalon S.1,3, Shirin H.1,2, Konikoff F.M.3,6, Naftali T.6

Created: Wednesday, 20 February 2019, 10:36 AM
P345: Risk of long-term post-operative recurrence (POR) in Crohn’s disease patients with a first postoperative normal endoscopic assessment under thiopurine prevention
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Mañosa1,2, M. Puig1, P. F. Torres1, F. Cañete1, J. Troya3, M. Calafat1, D. Parés3, E. Cabré1,2, E. Domènech1,2

Created: Friday, 22 February 2019, 9:41 AM
P345: The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Macaluso, F.S.(1);Grova, M.(1);Saladino, M.(2);Demarzo, M.G.(3);Privitera, A.C.(4);Giangreco, E.(5);Garufi, S.(6);Renna, S.(1);Casà, A.(1);Ventimiglia, M.(7);Cappello, M.(2);Fries, W.(3);Orlando, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P345: The Great Continental Divide: use of anti-TNF therapy in paediatric inflammatory bowel disease is significantly different in North America compared with other parts of the world.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Church1, J. Hyams2, F. Ruemmele3, L. de Ridder4, D. Turner5, A. Griffiths*1, o.b.o. the International Paediatric IBD Network (PIBDNet)6

Created: Friday, 22 February 2019, 9:49 AM
P346 Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn’s disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Liefferinckx1,2, M. Fassin2, D. Thomas3, C. Minsart1,2, A. Cremer1,2, L. Amininejad1, V. Tafciu2, V. Wambacq1, A. Van Gossum1, D. Franchimont1,2

Created: Thursday, 30 January 2020, 10:12 AM
P346: Chronic pouch failure rates after close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis.
Year: 2022
Source: ECCO'22
Authors: Reijntjes, M.(1);de Jong, D.(2);Bocharewicz, E.(1);Elise, W.(2);Duijvestein , M.(3);Bemelman, W.(1);
Created: Friday, 11 February 2022, 3:52 PM